Arkolith/Insider Trading/AIM/Form 4

Equels Thomas K

CEO & President, DirectorAIM ImmunoTech Inc. (AIM) · full profile →Form 4 · filed Mar 5, 2025
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2025Buy(P)44K$0.12$5K1.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-009164) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML